Evidence map›Paper›PMID 36873163›Full record

ReviewActa pharmaceutica Sinica. B2023

Developmental toxicity and programming alterations of multiple organs in offspring induced by medication during pregnancy.

Zhengjie Lu, Yu Guo, Dan Xu, Hao Xiao, Yongguo Dai, Kexin Liu, Liaobin Chen, Hui Wang

Open access · diamondAbstract readReview
In one paragraph

Review in Acta pharmaceutica Sinica. B, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
15.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. GLP-1-Mediated Pregnancy and Neonatal Complications in Mice.Journal of developmental biology · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Insulin-Like Growth Factor 2 Reverses Synaptic and Cognitive Deficits in Fetal Growth Restriction Mice.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Zhengjie LuDepartment of Pharmacology, Wuhan University School of Basic Medical Science, Wuhan 430071, China.
Yu GuoDepartment of Pharmacology, Wuhan University School of Basic Medical Science, Wuhan 430071, China.
Dan XuDepartment of Pharmacology, Wuhan University School of Basic Medical Science, Wuhan 430071, China.
Hao XiaoDepartment of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.
Yongguo DaiDepartment of Pharmacology, Wuhan University School of Basic Medical Science, Wuhan 430071, China.
Kexin LiuDepartment of Pharmacology, Wuhan University School of Basic Medical Science, Wuhan 430071, China.
Liaobin ChenDepartment of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.
Hui WangDepartment of Pharmacology, Wuhan University School of Basic Medical Science, Wuhan 430071, China.
Wuhan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Medication during pregnancy is widespread, but there are few reports on its fetal safety. Recent studies suggest that medication during pregnancy can affect fetal morphological and functional development through multiple pathways, multiple organs, and multiple targets. Its mechanisms involve direct ways such as oxidative stress, epigenetic modification, and metabolic activation, and it may also be indirectly caused by placental dysfunction. Further studies have found that medication during pregnancy may also indirectly lead to multi-organ developmental programming, functional homeostasis changes, and susceptibility to related diseases in offspring by inducing fetal intrauterine exposure to too high or too low levels of maternal-derived glucocorticoids. The organ developmental toxicity and programming alterations caused by medication during pregnancy may also have gender differences and multi-generational genetic effects mediated by abnormal epigenetic modification. Combined with the latest research results of our laboratory, this paper reviews the latest research progress on the developmental toxicity and functional programming alterations of multiple organs in offspring induced by medication during pregnancy, which can provide a theoretical and experimental basis for rational medication during pregnancy and effective prevention and treatment of drug-related multiple fetal-originated diseases.

Indexed as

Developmental programmingDevelopmental toxicityGender differencesMaternal-derived glucocorticoidsMedicationMulti-generational genetic effectsMultiple organsPregnancy

Identifiers

PMID36873163
PMCPMC9978644
OpenAlexW4281617433

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.